Medical Program: New Treatment Strategies for HER2+ Breast Cancer: The Latest from ASCO

New Treatment Strategies for HER2+ Breast Cancer: The Latest from ASCO

New Treatment Strategies for HER2+ Breast Cancer: The Latest from ASCO
RestartResume

What are the new strategies being developed to treat patients with HER2+ breast cancer? Check out the highlights from the 2020 ASCO Annual Meeting.

  • Overview

    There are several new strategies that have been emerging to treat patients with HER2+ breast cancer, and here to walk us through those that were highlighted at the 2020 ASCO Annual Meeting is Dr. Sara Tolaney, breast medical oncologist at the Dana-Farber Cancer Institute and Assistant Professor of Medicine at the Harvard Medical School.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free